Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-27 @ 11:49 PM
Study NCT ID:
NCT00963534
Status:
COMPLETED
Last Update Posted:
2018-03-12
First Post:
2009-08-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma.
Sponsor:
Lund University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-09
Start Date Type:
ACTUAL
Primary Completion Date:
2017-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-08
Completion Date Type:
ACTUAL
First Submit Date:
2009-08-20
First Submit QC Date:
None
Study First Post Date:
2009-08-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-09
Last Update Post Date:
2018-03-12
Last Update Post Date Type:
ACTUAL